DNA damage causes TP53-dependent coupling of self-renewal and senescence pathways in embryonal carcinoma cells

Cell Cycle. 2013 Feb 1;12(3):430-41. doi: 10.4161/cc.23285. Epub 2012 Feb 1.

Abstract

Recent studies have highlighted an apparently paradoxical link between self-renewal and senescence triggered by DNA damage in certain cell types. In addition, the finding that TP53 can suppress senescence has caused a re-evaluation of its functional role in regulating these outcomes. To investigate these phenomena and their relationship to pluripotency and senescence, we examined the response of the TP53-competent embryonal carcinoma (EC) cell line PA-1 to etoposide-induced DNA damage. Nuclear POU5F1/OCT4A and P21CIP1 were upregulated in the same cells following etoposide-induced G 2M arrest. However, while accumulating in the karyosol, the amount of OCT4A was reduced in the chromatin fraction. Phosphorylated CHK2 and RAD51/γH2AX-positive nuclear foci, overexpression of AURORA B kinase and moderate macroautophagy were evident. Upon release from G 2M arrest, cells with repaired DNA entered mitoses, while the cells with persisting DNA damage remained at this checkpoint or underwent mitotic slippage and gradually senesced. Reduction of TP53 using sh- or si-RNA prevented the upregulation of OCT4A and P21CIP1 and increased DNA damage. Subsequently, mitoses, micronucleation and senescence were all enhanced after TP53 reduction with senescence confirmed by upregulation of CDKN2A/P16INK4A and increased sa-β-galactosidase positivity. Those mitoses enhanced by TP53 silencing were shown to be multicentrosomal and multi-polar, containing fragmented and highly deranged chromosomes, indicating a loss of genome integrity. Together, these data suggest that TP53-dependent coupling of self-renewal and senescence pathways through the DNA damage checkpoint provides a mechanism for how embryonal stem cell-like EC cells safeguard DNA integrity, genome stability and ultimately the fidelity of self-renewal.

Keywords: DNA damage; OCT4A/POU5F1; TP53; pluripotency; self-renewal; senescence; tumor cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / pharmacology
  • Aurora Kinase B
  • Aurora Kinases
  • Autophagy
  • Cell Line, Tumor
  • Cellular Senescence / physiology*
  • Checkpoint Kinase 2
  • Cyclin-Dependent Kinase Inhibitor p16 / biosynthesis
  • Cyclin-Dependent Kinase Inhibitor p21 / biosynthesis
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics
  • DNA Damage / genetics*
  • DNA Repair / physiology*
  • Embryonal Carcinoma Stem Cells / metabolism
  • Etoposide / pharmacology
  • Female
  • G2 Phase Cell Cycle Checkpoints / drug effects
  • Histones / biosynthesis
  • Humans
  • Octamer Transcription Factor-3 / biosynthesis
  • Octamer Transcription Factor-3 / genetics
  • Ovarian Neoplasms
  • Phosphorylation
  • Protein Serine-Threonine Kinases / biosynthesis
  • RNA Interference
  • RNA, Small Interfering
  • Rad51 Recombinase / biosynthesis
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism*
  • Up-Regulation
  • beta-Galactosidase / biosynthesis

Substances

  • Antineoplastic Agents, Phytogenic
  • Cyclin-Dependent Kinase Inhibitor p16
  • Cyclin-Dependent Kinase Inhibitor p21
  • H2AX protein, human
  • Histones
  • Octamer Transcription Factor-3
  • POU5F1 protein, human
  • RNA, Small Interfering
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • Etoposide
  • Checkpoint Kinase 2
  • AURKB protein, human
  • Aurora Kinase B
  • Aurora Kinases
  • CHEK2 protein, human
  • Protein Serine-Threonine Kinases
  • RAD51 protein, human
  • Rad51 Recombinase
  • beta-Galactosidase